[1]BLUM KA,GUPTA S,TICKOO SK,et al.Sarcomatoid renal cell carcinoma:biology,natural history and management［J］.Nature Reviews Urology,2020,17(12):659-678.
[2] TULLY KH,BERG S,PACIOTTI M,et al.The natural history of renal-cell carcinoma with sarcomatoid differentiation,a stage-by-stage analysis［J］.Clinical Genitourinary Cancer,2023,21(1):63-68.
[3] ODEH S,SAMARSKA IV,MATOSO A,et al.Histologic reevaluation of a population based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classification［J］.Oncology Letters,2023,25(5):174.
[4] ZHAO Y,CHEN H,XIE Y,et al.Clinicopathologic features and prognostic factors in patients with renal cell carcinoma with sarcomatoid differentiation［J］.APMIS,2020,128(5):378-386.
[5] MENG X,SHU J,XIA Y,et al.A CT-based radiomics approach for the differential diagnosis of sarcomatoid and clear cell renal cell carcinoma［J］.BioMed Research International,2020,2020:7103647.
[6] ROUPRET M,SEISEN T,BIRTLE AJ,et al.European Association of Urology Guidelines on upper urinary tract urothelial carcinoma:2023 update［J］.European Urology,2023,84(1):49-64.
[7] JEONG D,RAGHUNAND N,HERNANDO D,et al.Quantification of sarcomatoid differentiation in renal cell carcinoma on magnetic resonance imaging［J］.Quantitative Imaging in Medicine and Surgery,2018,8(4):373-382.
[8] TULLY KH,BERG S,PACIOTTI M,et al.The natural history of renal-cell carcinoma with sarcomatoid differentiation,a stage-by-stage analysis［J］.Clinical Genitourinary Cancer,2022,21(1):63-68.
[9] 黄哲,李开艳.肾肉瘤样癌超声造影表现1例［J］.临床超声医学杂志,2019,21(5):380.
HUANG Z,LI KY.A case of renal sarcomatoid carcinoma with ultrasonographic presentation［J］.Journal of Clinical Ultrasound Medicine,2019,21(5):380.
[10] ROUSSEL E,CAPITANIO U,KUTIKOV A,et al.Novel imaging methods for renal mass characterization:A collaborative review［J］.European Urology,2022,81(5):476-488.
[11] BHANDARI A,IBRAHIM M,SHARMA C,et al.CT-based radiomics for differentiating renal tumours:a systematic review［J］.Abdominal Radiology(New York),2021,46(5):2052-2063.
[12] SHIRKHODA A,LEWIS E.Renal sarcoma and sarcomatoid renal cell carcinoma:CT and angiographic features［J］.Radiology,1987,162(2):353-357.
[13] SCHIEDA N,THORNHILL RE,AL-SUBHI M,et al.Diagnosis of sarcomatoid renal cell carcinoma with CT:Evaluation by qualitative imaging features and texture analysis［J］.AJR,2015,204(5):1013-1023.
[14] ALMURADOVA E,BASOGLU T,NAYIR E,et al.Real-life experience of patients with sarcomatoid renal cell carcinoma:a multicenter retrospective study［J］.Neoplasma,2023,70(1):158-165.
[15] TSILI A C,MOULOPOULOS LA,VARAKARAKIS IM,et al.Cross-sectional imaging assessment of renal masses with emphasis on MRI［J］.Acta Radiologica(Stockholm,Sweden:1987),2022,63(11):1570-1587.
[16] TAKEUCHI M,FROEMMING AT,KAWASHIMA A,et al.Magnetic resonance imaging(MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation［J］.Abdominal Radiology(New York),2022,47(6):2168-2177.
[17] TAKEUCHI M,URANO M,HARA M,et al.Characteristic MRI findings of sarcomatoid renal cell carcinoma dedifferentiated from clear cell renal carcinoma:radiological-pathological correlation［J］.Clinical Imaging,2013,37(5):908-912.
[18] TAKEUCHI M,KAWAI T,SUZUKI T,et al.MRI for differentiation of renal cell carcinoma with sarcomatoid component from other renal tumor types［J］.Abdominal Imaging,2015,40(1):112-119.
[19] MAZIN A,HAWKINS SH,STRINGFIELD O,et al.Identification of sarcomatoid differentiation in renal cell carcinoma by machine learning on multiparametric MRI［J］.Scientific Reports,2021,11(1):3785.
[20] CHENG M,DUZGOL C,KIM TH,et al.Sarcomatoid renal cell carcinoma:MRI features and their association with survival［J］.Cancer Imaging,2023,23(1):16.
[21] HU P,XU J,LI Q,et al.Tumor microenvironment-activated theranostic nanozymes for trimodal imaging-guided combined therapy［J］.Journal of Colloid and Interface Science,2024,660:585-596.
[22] HATAMIKIA S,GEORGE G,SCHWARZHANS F,et al.Breast MRI radiomics and machine learning-based predictions of response to neoadjuvant chemotherapy-How are they affected by variations in tumor delineation［J］.Computational and Structural Biotechnology Journal,2024,23:52-63.
[23] BAKOUNY Z,BRAUN DA,SHUKLA SA,et al.Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma［J］.Nature Communications,2021,12(1):808.
[24] NADEBAUM DP,HOFMAN MS,MITCHELL CA,et al.Oligometastatic renal cell carcinoma with sarcomatoid differentiation demonstrating variable imaging phenotypes on 68Ga-PSMA and 18F-FDG PET/CT:A case report and review of the literature［J］.Clinical Genitourinary Cancer,2017,23(17):30250.
[25] LIANG X,LIU Y,RAN P,et al.Sarcomatoid renal cell carcinoma:a case report and literature review［J］.BMC Nephrology,2018,19(1):84.
[26] FUSER D,HEDBERG ML,DEHNER LP,et al.Extensive metastatic sarcomatoid renal cell carcinoma evaluated by 18F-FDG PET/CT:a case report and review of literature［J］.Journal of Kidney Cancer and VHL,2018,5(1):1-6.
[27] ZHU H,ZHAO S,ZUO C,et al.FDG PET/CT and CT findings of renal cell carcinoma with sarcomatoid differentiation［J］.AJR,2020,215(3):645-651.
[28] CHEN SH,LIN BH,CHEN SM,et al.Head-to-head comparisons of enhanced CT,68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in identifying adverse pathology of clear-cell renal cell carcinoma:a prospective study［J］.International Braz J Urol,2023,49(6):716-731.
[29] TAKAHASHI M,KUME H,KOYAMA K,et al.Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT［J］.Clinical Nuclear Medicine,2015,40(12):936-940.
[30] WU Y,QI T,QIN X,et al.A nomogram based on the preoperative neutrophil-to-lymphocyte ratio to distinguish sarcomatoid renal cell carcinoma from clear cell renal cell carcinoma［J］.Frontiers in Oncology,2023,13:1218280.
[31] BLUM KA,GUPTA S,TICKOO SK,et al.Sarcomatoid renal cell carcinoma:biology,natural history and management［J］.Nature Reviews Urology,2020,17(12):659-678.
[32] ORTON MR,HANN E,DORAN SJ,et al.Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma:insights from the TRACERx Renal study［J］.Cancer Imaging,2023,23(1):76.
[33] WANG Y,SHANG W,XIONG J,et al.Activable nanoparticle for tumor aggressiveness and drug resistance prediction by glutathione heterogeneous imaging［J］.Journal of Biomedical Nanotechnology,2021,17(7):1339-1348.